Is Genfit SA halal to invest in?

According to Musaffa's Shariah screening methodology, Genfit SA (GNFT.PA) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company's business activities and financial ratios to determine whether it meets Islamic investment guidelines.

Is Genfit SA a Shariah-compliant stock?

A stock is Shariah-compliant if the company operates in permissible business activities and meets Islamic financial screening thresholds. Musaffa analyzes Genfit SA using these criteria to determine its compliance status.

Can Muslims buy shares of Genfit SA?

Muslim investors may consider investing in Genfit SA if it meets Shariah compliance standards. Investors typically review the company's business activities, debt levels, and non-permissible income before making a decision.

Why is Genfit SA classified as NOT HALAL?

Musaffa determines the Shariah status of Genfit SA by analyzing whether the company's core business operations are permissible and whether its financial ratios fall within accepted Islamic thresholds.

How often is the Shariah compliance for Genfit SA updated?

The Shariah compliance status of Genfit SA may be updated periodically when new financial statements, earnings reports, or business activity information become available.

Can a halal stock like Genfit SA become non-compliant?

Yes. A stock that is currently Shariah-compliant may become non-compliant if the company's financial ratios exceed Shariah thresholds or its business activities change.

Where can I check the Shariah status of Genfit SA?

You can check the latest Shariah compliance status of Genfit SA on Musaffa's stock page, where screening results and key financial indicators are updated to help Muslim investors make informed decisions.

Genfit SA GNFT.PA

€8.62 €0.20 (2.29%) 1D

Last Updated: May 15, 12:00 AM·XPAR

GNFT.PA Shariah Compliance

Screening Methodology: AAOIFI

NOT HALAL

Last Updated: April 21, 2026

Report Source: 2025 Annual Report

Analyst's Ratings for Genfit SA (GNFT.PA)

Based on 12 analysts giving stock ratings to Genfit SA in the past 3 months

Strong
SellSellHoldBuyStrong
Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Genfit SA. Stock Analysis GNFT.PA

France Health Care Small Cap Report: 2025 Annual

Genfit SA is a biopharmaceutical company involved in drug discovery and development for the early diagnosis, prevention and treatment of cardiometabolic diseases. The firm provides therapeutic and diagnostic solutions for rare and serious liver diseases , with a particular interest in diseases with largely unmet medical needs. Its laboratory capabilities include pharmacology, molecular and cellular biology, drug candidate screening, medicinal and analytical chemistry, biochemistry, omics analyses, and data science. Its in-house biobank allows to have unparalleled control and precision in the handling and preservation of biological samples, which is crucial to research. The firm leverage artificial intelligence (image processing tools and language models) to create tools that accelerate daily work and decision-making.

Key Statistics of Genfit SA (GNFT.PA)

Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.

Today's Range

€8.45€8.95

Today's Open

€8.82

Volume

36.39K

P/E Ratio (TTM)

52 Week Range

€3.05€9.72

Market Cap

408.08M

Avg. Volume

49.78K

Dividend Yield

Financial Metrics & Statements of Genfit SA (GNFT.PA)

FAQ's for Genfit SA (GNFT.PA)

According to Musaffa’s Shariah screening methodology, Genfit SA (GNFT.PA) is currently classified as NOT HALAL as of April 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.